Mechanisms of resistance to EGFR TKIs and development of a new generation of drugs in non-small-cell lung cancer [ J ] . J Biomed Biotechnol,2011:165-214 .MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired re ......